STXS
StereotaxisANYSE American / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
The bull case is that STXS now has a clearer strategic catalyst set: it exited 2025 with $13.4 million of cash, reported 2025 revenue of $32.4 million, and has a specific July 2026 window to close the Robocath acquisition, which could broaden its product footprint and reopen a growth narrative if execution is clean [#10-K-2026-03-12] [#8-K-2026-04-15].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Backlog conversion underwhelms and exposes weak demand visibility
Momentum
90
Value
37
Sentiment
73
Setup hits (3d)
— · Net —
AI TargetsBase $2.05 · Bull $2.80 · Bear $1.35
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net —
Target $4.13
Why
Momentum90 · Δ7d -
Value37 · Δ7d +0.1
Sentiment73 · Δ7d -
So what
Strength-led posture. Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
90
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.1
Sentiment
73
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 90.2 / Value 36.5 / Sentiment 73.0
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$151.49M
Beta
1.44
Shares Out
97.74M
P/E (TTM) · Derived
-6.2
P/S (TTM)
7.32
P/FCF (TTM) · Derived
-9.33
Rev YoY
-15.8%
EPS YoY
-10.7%
Gross Margin
+53.9%
Op Margin
-81.7%
Net Debt
-$7.99M
Current Ratio
1.55
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology